Pages
Products
Products
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

PDE Stable Cell Lines

OverviewProduct ListApplicationsCase StudiesFAQ

Overview

Phosphodiesterases (PDEs) regulate intracellular cyclic nucleotide signaling by hydrolyzing cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), or both. Through controlling these second messengers, PDEs influence a range of cellular processes, including proliferation, differentiation, metabolism, inflammation, and neuronal signaling.

The PDE superfamily comprises 11 families (PDE1–PDE11), with distinct substrate preferences, regulatory mechanisms, and tissue distributions. Some PDE families primarily hydrolyze cAMP, others preferentially act on cGMP, while several can metabolize both substrates.

PDE stable cell lines provide defined cellular models for studying selected PDE targets. Compared with transient expression systems, stable expression models can reduce variability associated with repeated transfection and support consistent experimental setups. They can be used in target-related functional studies and, when combined with appropriate analytical or reporter systems, in cellular evaluation of PDE inhibitors.

Fig. 1. cyclic nucleotide signaling pathways (Baillie G S, Tejeda GS, et al., 2019).

PDE Family Main Substrate Preference Research Considerations
PDE1 cAMP and cGMP Regulated by Ca²⁺/calmodulin
PDE3 cAMP and cGMP cGMP can competitively inhibit cAMP hydrolysis
PDE4 cAMP Important in cAMP-mediated signaling
PDE5 cGMP Primarily involved in cGMP signaling
PDE6 cGMP Closely associated with phototransduction
PDE6D Not a typical cyclic nucleotide-hydrolyzing PDE PDE6δ-related protein transport and localization studies

Product List

Applications PDE Stable Cell Lines

PDE Functional Studies

Investigate the cellular roles of individual PDE isoforms and their effects on cyclic nucleotide regulation.

PDE Inhibitor Screening

Evaluate candidate inhibitors in PDE-expressing cellular models using compatible functional readouts.

cAMP/cGMP Signaling Studies

Explore how PDE targets regulate intracellular second-messenger levels and downstream signaling.

PDE Isoform Selectivity Studies

Compare responses across different PDE isoforms to support cellular selectivity evaluation.

PDE Assay System Comparison

Different PDE research questions require different assay formats. Biochemical assays measure enzyme activity under defined conditions, while cell-based systems can provide information within a cellular environment.

Assay System Basic Principle Typical Applications Key Considerations
Biochemical PDE Assay Measures hydrolysis of cAMP or cGMP by purified PDE enzymes Enzyme inhibition, IC₅₀ determination, biochemical selectivity Does not fully represent intracellular signaling or cellular compound exposure
PDE-Expressing Cell Assay Uses cells expressing a selected PDE target; measures enzyme-related or downstream cellular responses Cellular target studies, functional evaluation, inhibitor assessment Requires a suitable assay readout and appropriate controls 
PDE Reporter Cell Assay Combines PDE expression with a reporter or biosensor system responsive to cyclic nucleotide changes Dynamic cellular monitoring, compound screening, pathway analysis Requires a compatible reporter system and assay-specific validation

Case Study

Goraya et al. established HEK293 stable cell lines expressing PDE1A2 and PDE1C4 to investigate how different PDE1 isoforms regulate intracellular cAMP signaling. Although both isoforms were predominantly cytosolic, they exhibited distinct kinetic properties. PDE1A2 had an approximately 30-fold higher \(K_m\) for cAMP than PDE1C4, while showing greater sensitivity to PDE inhibitors. Real-time cAMP measurements further revealed that PDE1C4 promoted faster cAMP hydrolysis following calcium entry. These findings demonstrate how PDE1 isoform-specific properties influence cellular cAMP dynamics.

Fig. 2. Characterization of Ca²⁺/calmodulin-dependent PDE activity in stable PDE1A2- and PDE1C4-expressing HEK293 cells (Goraya T A, Masada N, et al., 2008).

FAQ

What are PDE stable cell lines used for?

PDE stable cell lines are used to study selected phosphodiesterase targets in a defined cellular background. They can support PDE-related functional studies, cyclic nucleotide signaling research, and cellular evaluation of candidate inhibitors when paired with suitable assay readouts.

What are the differences between PDE1, PDE3, PDE4, and PDE5?

These families differ in substrate preference and regulatory mechanisms. PDE1 and PDE3 can hydrolyze both cAMP and cGMP; PDE4 primarily hydrolyzes cAMP; and PDE5 primarily hydrolyzes cGMP. These differences should be considered when selecting a target and designing an assay.

How should I choose a suitable PDE stable cell line?

Start by identifying the PDE family and isoform relevant to your research. Then consider substrate preference, host cell background, target expression information, and the assay readout required for your study. For PDE6D, consider protein interaction and trafficking-related research rather than conventional PDE enzyme activity measurements.

What validation information is available for these PDE stable cell lines?

Validation information may vary by product. Please refer to the corresponding product detail page for available target expression, host cell, specifications, and quality-control information. Contact our team if you require additional documentation or need to confirm product suitability.

Looking for a Specific PDE Cell Model?

Whether you are selecting an existing PDE stable cell line or planning a customized PDE research project, our team can help you identify an appropriate model and discuss your experimental requirements.

References:

  1. Goraya TA, Masada N, et al. Kinetic properties of Ca2+/calmodulin-dependent phosphodiesterase isoforms dictate intracellular cAMP dynamics in response to elevation of cytosolic Ca2+. Cell Signal. 2008 Feb;20(2):359-74.
  2. Baillie, G.S., Tejeda, G.S. et al. Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond. Nat Rev Drug Discov 18, 770–796 (2019).
* For research use only. Not intended for any clinical use.
Quick Inquiry